Division of Nephrology, Foothills Medical Centre, Calgary, AB, T2N 0L9, Canada.
Clin J Am Soc Nephrol. 2010 Mar;5(3):425-30. doi: 10.2215/CJN.06530909. Epub 2010 Jan 14.
IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide. Accurately identifying patients who are at risk for progressive disease is challenging. The extent to which histopathologic features improves prognostication is uncertain.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We studied a retrospective cohort with biopsy-proven IgAN in Calgary, Canada. Renal biopsies were reviewed by a nephropathologist with histopathologic data abstracted using a standardized form. The primary outcome was the composite of doubling of serum creatinine, ESRD, or death. Spline models defined significant levels of interstitial fibrosis, glomerulosclerosis, hypertension, proteinuria, and creatinine. The prognostic significances of clinical and histopathologic parameters were determined using Cox proportional hazards models.
Data from 146 cases were available for analysis with a median follow-up of 5.8 years. Greater than 25% interstitial fibrosis, >40% glomerular sclerosis, and a systolic BP >150 mmHg were risk thresholds. In univariable analyses, baseline creatinine, proteinuria, systolic BP, glomerular sclerosis, interstitial fibrosis, and crescentic disease were predictors of the primary outcome. In multivariable models adjusted for clinical characteristics, interstitial fibrosis (hazard ratio [HR]2.7; 95% confidence interval [CI] 1.2 to 6.0), glomerular sclerosis (HR 2.6; 95% CI 1.2 to 4.5), and crescents (HR 2.4; 95% CI 1.2 to 5.1) remained independent predictors of the primary outcome and significantly improved model fit compared with clinical characteristics alone.
Baseline histopathologic parameters are independent predictors of adverse outcomes in IgAN even after taking into consideration clinical characteristics. Relatively small degrees of interstitial fibrosis confer an increased risk for progressive IgAN.
IgA 肾病(IgAN)是全球最常见的原发性肾小球疾病。准确识别有进展性疾病风险的患者具有挑战性。组织病理学特征对预后的改善程度尚不确定。
设计、地点、参与者和测量方法:我们研究了加拿大卡尔加里的活检证实的 IgAN 回顾性队列。肾病学家对肾脏活检进行了回顾,并使用标准化表格提取了组织病理学数据。主要结局是血清肌酐加倍、终末期肾病或死亡的复合结局。样条模型定义了间质纤维化、肾小球硬化、高血压、蛋白尿和肌酐的显著水平。使用 Cox 比例风险模型确定临床和组织病理学参数的预后意义。
共有 146 例病例的数据可用于分析,中位随访时间为 5.8 年。大于 25%的间质纤维化、大于 40%的肾小球硬化和收缩压大于 150mmHg 是风险阈值。在单变量分析中,基线肌酐、蛋白尿、收缩压、肾小球硬化、间质纤维化和新月体肾炎是主要结局的预测因素。在调整临床特征的多变量模型中,间质纤维化(危险比[HR]2.7;95%置信区间[CI]1.2 至 6.0)、肾小球硬化(HR 2.6;95%CI 1.2 至 4.5)和新月体(HR 2.4;95%CI 1.2 至 5.1)仍然是主要结局的独立预测因素,与仅考虑临床特征相比,模型拟合度显著提高。
即使考虑到临床特征,基线组织病理学参数也是 IgAN 不良结局的独立预测因素。相对较小程度的间质纤维化增加了 IgAN 进展的风险。